文献速递肿瘤 PET/CT骨显像与常规 SPECT

68Ga-PSMA PET/CT在高危前列腺癌原发淋巴结分期中的准确性

The accuracy of 68Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2017-06-18

土耳其多中心研究纳入51例高危/极高危非转移性前列腺癌患者,比较68Ga-PSMA PET/CT与形态学影像(MRI或CT)对淋巴结转移的诊断准确性。PSMA PET/CT灵敏度53%、特异度86%、准确率76%,在切除≥15枚淋巴结亚组升至67%、88%、81%;与病理相关性Kappa值PSMA PET为0.41,形态学影像为0.18。

要点

  • PSMA PET/CT诊断淋巴结转移灵敏度53%、特异度86%、准确率76%。
  • 切除≥15枚淋巴结亚组灵敏度67%、特异度88%、准确率81%。
  • 与病理相关性Kappa值PSMA PET 0.41,形态学影像0.18。

核心结论

  • PSMA PET/CT在原发前列腺癌患者转移淋巴结检测方面优于形态学影像。
  • 手术清扫仍是精确淋巴分期的金标准。

研究设计与样本

  • 土耳其泌尿肿瘤学会与伊斯坦布尔大学Cerrahpasa医学院核医学科联合开展的多中心试验,自8个中心纳入患者。
  • 纳入2014年7月至2015年10月间计划接受扩大淋巴结清扫手术的高危和极高危前列腺癌患者,共51例 eligible 患者数据。
  • 形态学影像采用MRI或CT,PSMA PET/CT在单中心进行和评估。

主要发现

  • PSMA PET在原发分期中检测淋巴结转移的灵敏度53%、特异度86%、准确率76%。
  • 在切除≥15枚淋巴结的患者亚组中,灵敏度67%、特异度88%、准确率81%。
  • 影像与病理相关性Kappa值:PSMA PET为0.41,形态学影像为0.18。

关键数值与推荐

  • PSMA PET/CT检测淋巴结转移的灵敏度53%、特异度86%、准确率76%。
  • 切除≥15枚淋巴结亚组灵敏度67%、特异度88%、准确率81%。
  • Kappa值PSMA PET 0.41,形态学影像0.18。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess the diagnostic accuracy of 68Ga-PSMA PET in predicting lymph node (LN) metastases in primary N staging in high-risk and very high-risk nonmetastatic prostate cancer in comparison with morphological imaging. METHODS: This was a multicentre trial of the Society of Urologic Oncology in Turkey in conjunction with the Nuclear Medicine Department of Cerrahpasa School of Medicine, Istanbul University. Patients were accrued from eight centres. Patients with high-risk and very high-risk disease scheduled to undergo surgical treatment with extended LN dissection between July 2014 and October 2015 were included. Either MRI or CT was used for morphological imaging. PSMA PET/CT was performed and evaluated at a single centre. Sensitivity, specificity and accuracy were calculated for the detection of lymphatic metastases by PSMA PET/CT and morphological imaging. Kappa values were calculated to evaluate the correlation between the numbers of LN metastases detected by PSMA PET/CT and by histopathology. RESULTS: Data on 51 eligible patients are presented. The sensitivity, specificity and accuracy of PSMA PET in detecting LN metastases in the primary setting were 53%, 86% and 76%, and increased to 67%, 88% and 81% in the subgroup with of patients with ≥15 LN removed. Kappa values for the correlation between imaging and pathology were 0.41 for PSMA PET and 0.18 for morphological imaging. CONCLUSIONS: PSMA PET/CT is superior to morphological imaging for the detection of metastatic LNs in patients with primary prostate cancer. Surgical dissection remains the gold standard for precise lymphatic staging.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Öbek C, Doğanca T, Demirci E, et al. The accuracy of 68Ga-PSMA PET/CT in primary lymph node staging in high-risk prostate cancer. Eur J Nucl Med Mol Imaging. 2017. PMID: 28624849. doi:10.1007/s00259-017-3752-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。